AskBorsa

SPINALEX results, Fiscal year 2024

Net profit, assets, equity and cash flow for Fiscal year 2024, against the same period a year earlier, from the published financial statements. fiscal year starts in July.

Net profit115 millionEGP · +28.2% vs the same period a year earlier
Total assets1.08 billionEGP · +20.8% vs the same period a year earlier
Shareholders' equity783 millionEGP · +13.6% vs the same period a year earlier
Operating cash flow-97.8 millionEGP · −751.3% vs the same period a year earlier

In short

  • SPINALEX's net profit for Fiscal year 2024 was about 115 million EGP, up +28.2% from 89.86 million EGP in Fiscal year 2023.
  • Total assets at the end of Fiscal year 2024 were about 1.08 billion EGP, and shareholders' equity about 783 million EGP.
  • Operating cash flow for Fiscal year 2024 was negative at 97.8 million EGP.
Source: the Fiscal year 2024 financial statements

Key lines against the same period a year earlier

This periodFiscal year 2023Change
Net profit115 million89.86 million+28.2%
Gross profit111 million85.99 million+29.4%
Total assets1.08 billion893 million+20.8%
Total liabilities296 million204 million+44.9%
Shareholders' equity783 million689 million+13.6%
Total liabilities and equity1.08 billion893 million+20.8%
Operating cash flow-97.8 million-11.49 million−751.3%
Investing cash flow62.96 million56.89 million+10.7%
Financing cash flow22.14 million26.86 million−17.6%
Net change in cash-12.7 million72.27 million−117.6%

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.

Official report (PDF)All of SPINALEX's statements, five yearsAsk the AI analyst about SPIN

SPINALEX's Fiscal year 2026 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for SPINALEX